Europe’s High: Irish GPs Against Pot, Switzerland-Spain Share Data On Cannabis Clubs & More
Denmark: Medical Marijuana Pilot Program Experience 90% Growth In 12 Months
New Jersey Adult-Use Cannabis Licensing Advances As TerrAscend Faces Scrutiny
The New Jersey Cannabis Regulatory Commission (NJ-CRC) recently made significant strides in the state's cannabis industry by granting approvals for numerous licenses.
Small Pharma’s Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business
Small Pharma Inc. (OTCQB: DMTTF), the short-acting psychedelics biotech about to be purchased by Cybin Inc.
Exploring New Trends In Cannabis Products: A Fusion Of Culture & Innovation
The world of cannabis products is continually evolving, offering a diverse array of choices that cater to various consumer preferences.
Semrush Index: Mental Health, War On Drugs And Sustainability Dominate Global Online Concerns
Discover top global issues from Semrush's 2023 Index. Uncover trends from millions of Google searches. Data-driven change awaits.
More Savings, No Disruptions: Canadian Weed Co. Makes Strategic Move To Boost Operations
SNDL Inc. (NASDAQ: SNDL) announced additional optimizations of its facility footprint on Thursday to boost its cannabis operations segment.
Cannabis Stock Gainers And Losers From October 19, 2023
GAINERS: EVIO (OTC:EVIO) shares closed up 100.00% at $0.0001 Choom Holdings (OTC:CHOOF) shares closed up 25.00% at $0.0005…
Five Hours Of Pain Relief? Preclinical Study Shows Promising Results With This Non-Toxic CBD
MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) announced on Thursday the results from a preclinical study of its investigational cannabinoid Supera-CBD, a novel, synthetic, non-toxic cannabidiol (CBD) analog.
Cannabis Giants Pivot Amid Falling Prices And Oversupply: Some Turn To Flowers And Veggies
Canada's leading cannabis producers are adapting to industry challenges by diversifying their cultivation to include vegetables, fruits and flowers.
Cresco Labs Unlocks $32M In Non-Dilutive Capital Strengthening Overall Business
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) closed the sale of its sole licensed Arizona operation (“Encanto”) to an affiliate of Mint Cannabis for an aggregate purchase price of $6.5 million in cash.